Evidence map›Paper›PMID 36978330›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Mohamed F Ghaly, Marzough Aziz Albalawi, Mahmoud M Bendary, Ahmed Shahin, Mohamed A Shaheen, Abeer F Abu Eleneen, Mohammed M Ghoneim, Ayman Abo Elmaaty, Mohamed F M Elrefai, Sawsan A Zaitone and 1 more

Open access · goldFull text read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. The Health Benefits ofNutrients · 2026
    Review
  5. Comparative phenotypic and genotypic analysis of distinctFrontiers in cellular and infection microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Partnering essential oils with antibiotics: proven therapies against bovineFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Mohamed F GhalyBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Marzough Aziz AlbalawiDepartment of Chemistry, Alwajh College, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0003-4579-0045
Mahmoud M BendaryDepartment of Microbiology and Immunology, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt.
Ahmed ShahinMicrobiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.
Mohamed A ShaheenClinical Pathology Department, Faculty of Medicine, Al-Azhar University, Cairo 11311, Egypt.
Abeer F Abu EleneenBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Mohammed M GhoneimDepartment of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia.ORCID 0000-0002-9179-4373
Ayman Abo ElmaatyMedicinal Chemistry Department, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt.ORCID 0000-0002-4634-3039
Mohamed F M ElrefaiAnatomy, Histology, Physiology and Biochemistry Department, Faculty of Medicine, Hashemite University, Zarqa 13116, Jordan.
Sawsan A ZaitoneDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0002-9688-7683
Amira I AbousatyBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Zagazig University · EGPort Said University · EGAin Shams University · EGAl-Azhar University · EGAlfaisal University · SASuez Canal University · EGUniversity of Tabuk · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The worldwide crises from multi-drug-resistant (MDR) bacterial infections are pushing us to search for new alternative therapies. The renewed interest in medicinal plants has gained the attention of our research group.

Indexed as

antivirulenceFICIMBCMICmolecular dockingTamarindus indica

Identifiers

PMID36978330
PMCPMC10044421
OpenAlexW4322500952

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read31
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.